Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcus aureus | 49 | 2023 | 1450 | 6.120 |
Why?
|
| Staphylococcal Infections | 33 | 2023 | 1395 | 4.080 |
Why?
|
| Bacterial Capsules | 19 | 2019 | 242 | 3.530 |
Why?
|
| Staphylococcal Vaccines | 11 | 2021 | 32 | 3.410 |
Why?
|
| Polysaccharides, Bacterial | 14 | 2019 | 569 | 2.290 |
Why?
|
| Antibodies, Bacterial | 10 | 2021 | 1443 | 1.090 |
Why?
|
| Bacterial Toxins | 4 | 2021 | 927 | 0.980 |
Why?
|
| Coagulase | 3 | 2016 | 53 | 0.920 |
Why?
|
| Bacterial Proteins | 17 | 2023 | 3784 | 0.910 |
Why?
|
| Staphylococcal Skin Infections | 6 | 2021 | 76 | 0.880 |
Why?
|
| Antigens, Bacterial | 6 | 2016 | 1152 | 0.710 |
Why?
|
| Virulence Factors | 4 | 2021 | 502 | 0.700 |
Why?
|
| Cytotoxins | 1 | 2018 | 152 | 0.590 |
Why?
|
| Bacterial Vaccines | 3 | 2016 | 397 | 0.580 |
Why?
|
| Bacteremia | 7 | 2017 | 967 | 0.550 |
Why?
|
| Hemolysin Proteins | 1 | 2016 | 111 | 0.550 |
Why?
|
| Cell Wall | 4 | 2018 | 420 | 0.540 |
Why?
|
| Abscess | 5 | 2016 | 600 | 0.530 |
Why?
|
| Immunization, Passive | 5 | 2016 | 612 | 0.510 |
Why?
|
| Inflammasomes | 1 | 2020 | 515 | 0.490 |
Why?
|
| Soft Tissue Infections | 1 | 2016 | 161 | 0.490 |
Why?
|
| Teichoic Acids | 2 | 2015 | 68 | 0.480 |
Why?
|
| Wound Infection | 1 | 2016 | 242 | 0.470 |
Why?
|
| Anti-Bacterial Agents | 11 | 2021 | 7222 | 0.460 |
Why?
|
| Surgical Wound Infection | 3 | 2016 | 1488 | 0.460 |
Why?
|
| Cross Reactions | 1 | 2014 | 812 | 0.420 |
Why?
|
| Neutrophils | 7 | 2021 | 3706 | 0.410 |
Why?
|
| Bacterial Adhesion | 3 | 2015 | 307 | 0.400 |
Why?
|
| Polysaccharides | 2 | 2019 | 1006 | 0.380 |
Why?
|
| Staphylococcus haemolyticus | 2 | 2007 | 6 | 0.380 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2022 | 685 | 0.370 |
Why?
|
| Staphylococcus | 1 | 2010 | 155 | 0.350 |
Why?
|
| Macrophages | 3 | 2021 | 5652 | 0.350 |
Why?
|
| Fibrinogen | 2 | 2016 | 865 | 0.340 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 1896 | 0.340 |
Why?
|
| Mice | 27 | 2023 | 80087 | 0.330 |
Why?
|
| Chemokines, CXC | 2 | 2008 | 418 | 0.310 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2013 | 4296 | 0.310 |
Why?
|
| Bacterial Load | 3 | 2017 | 150 | 0.300 |
Why?
|
| Gastrointestinal Diseases | 1 | 2015 | 1169 | 0.280 |
Why?
|
| Sepsis | 2 | 2018 | 2589 | 0.280 |
Why?
|
| Virulence | 7 | 2021 | 1292 | 0.280 |
Why?
|
| Animals | 35 | 2023 | 166331 | 0.270 |
Why?
|
| Glycoproteins | 1 | 2013 | 2201 | 0.260 |
Why?
|
| Vaccines, Subunit | 2 | 2016 | 166 | 0.260 |
Why?
|
| Adhesins, Bacterial | 1 | 2006 | 118 | 0.260 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 2 | 2016 | 49 | 0.260 |
Why?
|
| Disease Models, Animal | 15 | 2021 | 17834 | 0.250 |
Why?
|
| Opsonin Proteins | 3 | 2016 | 146 | 0.250 |
Why?
|
| Diabetes Complications | 1 | 2011 | 1318 | 0.240 |
Why?
|
| Gene Expression Regulation, Bacterial | 6 | 2019 | 1113 | 0.240 |
Why?
|
| Vaccines, Synthetic | 3 | 2016 | 600 | 0.230 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2008 | 653 | 0.230 |
Why?
|
| Phagocytosis | 3 | 2016 | 1523 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2023 | 7785 | 0.220 |
Why?
|
| Nasal Mucosa | 1 | 2006 | 410 | 0.210 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 1095 | 0.210 |
Why?
|
| Rabbits | 5 | 2021 | 4783 | 0.210 |
Why?
|
| Skin Diseases | 1 | 2010 | 1081 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 1442 | 0.200 |
Why?
|
| Diabetic Foot | 1 | 2005 | 364 | 0.200 |
Why?
|
| Escherichia coli | 1 | 2013 | 4163 | 0.190 |
Why?
|
| Vaccines, Conjugate | 4 | 2017 | 322 | 0.190 |
Why?
|
| Erythromycin | 1 | 2021 | 117 | 0.190 |
Why?
|
| Blood Bactericidal Activity | 2 | 2014 | 126 | 0.190 |
Why?
|
| Osmotic Pressure | 1 | 2021 | 148 | 0.180 |
Why?
|
| Mice, Inbred ICR | 2 | 2014 | 344 | 0.180 |
Why?
|
| Membrane Fluidity | 1 | 2020 | 67 | 0.180 |
Why?
|
| HL-60 Cells | 1 | 2021 | 363 | 0.180 |
Why?
|
| Mastitis | 3 | 2016 | 43 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4335 | 0.170 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2020 | 133 | 0.170 |
Why?
|
| Carbohydrate Sequence | 2 | 2010 | 410 | 0.160 |
Why?
|
| Peptidoglycan | 2 | 2018 | 248 | 0.160 |
Why?
|
| Amyloid | 1 | 2023 | 811 | 0.160 |
Why?
|
| Immunity, Innate | 2 | 2016 | 3017 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 6095 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2018 | 10127 | 0.140 |
Why?
|
| Cell Survival | 2 | 2021 | 5761 | 0.140 |
Why?
|
| Blood Platelets | 1 | 2007 | 2478 | 0.140 |
Why?
|
| Multigene Family | 3 | 2019 | 1075 | 0.130 |
Why?
|
| Cystic Fibrosis | 2 | 2016 | 1252 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 3 | 2017 | 1026 | 0.130 |
Why?
|
| Pneumonia, Staphylococcal | 2 | 2013 | 40 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 83 | 0.130 |
Why?
|
| Microvilli | 1 | 2016 | 235 | 0.130 |
Why?
|
| Apoptosis | 1 | 2011 | 9421 | 0.130 |
Why?
|
| Endocytosis | 1 | 2020 | 979 | 0.130 |
Why?
|
| Cross Protection | 1 | 2014 | 24 | 0.120 |
Why?
|
| Lipoproteins | 1 | 2020 | 881 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 236 | 0.120 |
Why?
|
| Drug Compounding | 1 | 2016 | 247 | 0.120 |
Why?
|
| Biofilms | 3 | 2022 | 605 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2021 | 1872 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 21529 | 0.120 |
Why?
|
| Hydro-Lyases | 1 | 2014 | 93 | 0.120 |
Why?
|
| Temperature | 1 | 2021 | 2194 | 0.120 |
Why?
|
| Hindlimb | 2 | 2006 | 501 | 0.110 |
Why?
|
| Biological Therapy | 1 | 2015 | 133 | 0.110 |
Why?
|
| Carrier State | 2 | 2016 | 520 | 0.110 |
Why?
|
| Glycerophosphates | 1 | 2013 | 46 | 0.110 |
Why?
|
| Glycoconjugates | 1 | 2013 | 87 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2014 | 133 | 0.110 |
Why?
|
| Osteomyelitis | 2 | 2016 | 397 | 0.110 |
Why?
|
| Microbial Viability | 1 | 2014 | 236 | 0.110 |
Why?
|
| Adaptation, Biological | 1 | 2013 | 146 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 17675 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2014 | 1227 | 0.100 |
Why?
|
| Genetic Engineering | 1 | 2018 | 930 | 0.100 |
Why?
|
| Leukocidins | 2 | 2008 | 17 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2020 | 18891 | 0.100 |
Why?
|
| Bacteriophages | 1 | 2015 | 366 | 0.100 |
Why?
|
| Exotoxins | 2 | 2008 | 120 | 0.100 |
Why?
|
| Placebos | 1 | 2016 | 1658 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2015 | 770 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 1972 | 0.090 |
Why?
|
| Genes, Bacterial | 3 | 2006 | 1060 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 1349 | 0.090 |
Why?
|
| Vaccination | 2 | 2018 | 3282 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3025 | 0.090 |
Why?
|
| Vancomycin | 1 | 2013 | 495 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 248 | 0.090 |
Why?
|
| Proteomics | 1 | 2023 | 3709 | 0.080 |
Why?
|
| Electrolytes | 1 | 2010 | 280 | 0.080 |
Why?
|
| Gentamicins | 1 | 2010 | 250 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3742 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2021 | 3657 | 0.080 |
Why?
|
| Epitopes | 1 | 2014 | 2505 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2007 | 316 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 198 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3722 | 0.070 |
Why?
|
| Genetic Complementation Test | 3 | 2015 | 555 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2013 | 1858 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 4480 | 0.070 |
Why?
|
| Operon | 2 | 2019 | 365 | 0.070 |
Why?
|
| Receptors, Leptin | 1 | 2008 | 346 | 0.070 |
Why?
|
| Humans | 24 | 2023 | 746044 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2016 | 9105 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2012 | 1031 | 0.070 |
Why?
|
| Cattle | 3 | 2008 | 3840 | 0.070 |
Why?
|
| Genome, Bacterial | 2 | 2015 | 751 | 0.070 |
Why?
|
| Female | 15 | 2021 | 382109 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 828 | 0.070 |
Why?
|
| Vaccines, Inactivated | 1 | 2006 | 180 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1762 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 5760 | 0.060 |
Why?
|
| Respiratory Burst | 1 | 2005 | 108 | 0.060 |
Why?
|
| Serotyping | 1 | 2005 | 322 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 377 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 2987 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8125 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 11940 | 0.060 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 445 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 500 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2006 | 468 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 264 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3695 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2007 | 1877 | 0.060 |
Why?
|
| Family Health | 1 | 2008 | 1255 | 0.060 |
Why?
|
| Uridine Diphosphate Sugars | 1 | 2002 | 10 | 0.060 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 2002 | 17 | 0.050 |
Why?
|
| Complement C3 | 1 | 2005 | 456 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2022 | 240 | 0.050 |
Why?
|
| Vitamin K 3 | 1 | 2021 | 14 | 0.050 |
Why?
|
| O Antigens | 1 | 2002 | 188 | 0.050 |
Why?
|
| Base Sequence | 3 | 2012 | 12447 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 1822 | 0.050 |
Why?
|
| Rats | 4 | 2016 | 23680 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 1809 | 0.050 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 1439 | 0.050 |
Why?
|
| Transcription, Genetic | 3 | 2019 | 7571 | 0.050 |
Why?
|
| Point Mutation | 1 | 2006 | 1600 | 0.050 |
Why?
|
| Nose | 2 | 2015 | 510 | 0.040 |
Why?
|
| Urea | 1 | 2022 | 435 | 0.040 |
Why?
|
| Antibodies | 1 | 2008 | 2406 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2015 | 4703 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3133 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2008 | 1730 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1760 | 0.040 |
Why?
|
| RNA, Bacterial | 2 | 2015 | 382 | 0.040 |
Why?
|
| Sigma Factor | 1 | 2019 | 174 | 0.040 |
Why?
|
| Phenotype | 1 | 2015 | 16245 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2015 | 1172 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2022 | 1154 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2005 | 1353 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2007 | 5835 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2020 | 23112 | 0.030 |
Why?
|
| Immunization | 1 | 2021 | 1219 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2019 | 2964 | 0.030 |
Why?
|
| Complement C3b | 1 | 2016 | 99 | 0.030 |
Why?
|
| Cell Line | 1 | 2010 | 15631 | 0.030 |
Why?
|
| Chromosomes, Bacterial | 2 | 2008 | 279 | 0.030 |
Why?
|
| Mutation | 3 | 2016 | 29614 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10300 | 0.030 |
Why?
|
| Suramin | 1 | 2014 | 34 | 0.030 |
Why?
|
| Ceramides | 1 | 2016 | 201 | 0.030 |
Why?
|
| Quorum Sensing | 1 | 2015 | 131 | 0.030 |
Why?
|
| Ampicillin | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cell Movement | 1 | 2006 | 5162 | 0.030 |
Why?
|
| DNA Primers | 2 | 2012 | 2810 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 664 | 0.030 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 339 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 31 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 458 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2013 | 110 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1997 | 904 | 0.030 |
Why?
|
| Immune Sera | 1 | 2013 | 613 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 2013 | 192 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 7935 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2846 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2016 | 540 | 0.030 |
Why?
|
| Male | 8 | 2021 | 351093 | 0.030 |
Why?
|
| Kinetics | 2 | 2014 | 6352 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2013 | 772 | 0.020 |
Why?
|
| Binding Sites | 1 | 2019 | 6025 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 894 | 0.020 |
Why?
|
| Static Electricity | 1 | 2010 | 264 | 0.020 |
Why?
|
| Bronchi | 1 | 2013 | 842 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2010 | 187 | 0.020 |
Why?
|
| Methicillin | 1 | 2008 | 62 | 0.020 |
Why?
|
| Actins | 1 | 2016 | 2050 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2016 | 1892 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2016 | 1395 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1653 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 2275 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9278 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1283 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 1879 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1511 | 0.020 |
Why?
|
| Synteny | 1 | 2005 | 77 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 388 | 0.020 |
Why?
|
| Gene Order | 1 | 2005 | 170 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2005 | 199 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3782 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2005 | 120 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 6508 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 2662 | 0.020 |
Why?
|
| Iron | 1 | 2012 | 1735 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 1420 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4114 | 0.010 |
Why?
|
| Electrophoresis, Capillary | 1 | 2002 | 62 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12202 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2005 | 749 | 0.010 |
Why?
|
| Cross Infection | 1 | 2010 | 1420 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4576 | 0.010 |
Why?
|
| Catalysis | 1 | 2002 | 764 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2005 | 1126 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7580 | 0.010 |
Why?
|
| Biological Evolution | 1 | 2005 | 1057 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 510 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 12039 | 0.010 |
Why?
|
| Genotype | 1 | 2013 | 12773 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 63661 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 1024 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5413 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14113 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 237 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2002 | 2171 | 0.010 |
Why?
|
| Lung | 1 | 2013 | 9842 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14211 | 0.010 |
Why?
|
| Child | 2 | 2013 | 78456 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2194 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 2077 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16657 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 9116 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 57106 | 0.000 |
Why?
|
| Adult | 2 | 2013 | 214958 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2002 | 12741 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 41376 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 13494 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 86202 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2013 | 78297 | 0.000 |
Why?
|
Concepts
(272)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_